References
- Karchmer A. Infections of prosthetic valve endocarditis and intravascular devices. in Mandell GL, Bennett JE, Dolin E. (eds). Principles and Practice of Infectious Diseases; 5th ed. Philadelphia: Churchill Livingstone Press. 2000: 903–17.
- Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318–30.
- Calderwood SB, Swinski LA, Karchmer AW, et al. Prosthetic valve endocarditis: analysis of factors affecting out-come of therapy. J Thorac Cardiovasc Surg 1986; 92: 776–83.
- Perry CM, Jarvis B. Linezolid. A review of its use in the management of serious gram-positive infections. Drugs 2001; 61: 521–51,
- Bishara J, Leibovici L, Gartman-Israel D, et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis 2001; 33: 1636–43,
- Vouillamoz J, Entenza JM, Feger C, et al. Quinupristin-dalf opristin combined with beta-lactams for the treatment of experimental endocarditis due to S. aureus constitutively resistant to macrolide/lincosamide/streptogramin-, antibiotics. Antimicrob Agents Chemother 2000; 44: 1789–95.
- COCITO C, Di Giambattista M, Nyssen E, Vannuf fel P. Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother 1997; 39 (Suppl. A): 7-13.
- Chevalier P, Rey J, Pasquier O, et al. Pharmacokinetics of quinupristin/dalfopristin in patients with severe chronic renal insufficiency. Clin Pharmacokinet 2000; 39: 77–84.
- Working Party of the British Society of Antimicrobial Chemotherapy. Antibiotic treatment for streptococcal, entero-coccal and staphylococcal endocarditis. Heart 1998; 79: 207–10.
- Wilson WR, Karchmer AW, Dajani AF, et al. Antibiotic treatment of adults with infective endocarditis due to strepto-cocci, enterococci and staphylococci and HACEK microorgan-isms. JAMA 1995; 274: 1706–13.